We previously reported the presence of mitotic checkpoint impairment in about 40% of lung cancer cell lines. To gain an insight into the molecular basis of this impairment, we examined 49 lung cancer specimens for alterations in the hMAD1 mitotic checkpoint gene and identi®ed a somatic, non-conservative missense mutation, which substitutes alanine (GCG) for threonine (ACG) at codon 299, together with a number of amino acid substituting, single nucleotide polymorphisms. This is the ®rst demonstration of hMAD1 mutation in any type of human cancers. The present ®nding marks hMAD1 as a potential target, although with low frequency, for genetic alterations in lung cancer. Thus, further studies of hMAD1 dysfunction caused by other mechanisms appear to be warranted, as well as potential involvement of other components of the mitotic checkpoint.
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Keywords: lung cancer; mitotic checkpoint; hMAD1; somatic mutation; genetic instability Lung cancer currently claims more than 160 000 lives annually as the number one cause of cancer deaths in the US, while it is also expected to become the leading cause in Japan (Statistics and Information Department, 1998) . Recent molecular biological studies have clearly indicated that lung cancer is a disease caused by accumulation of multiple genetic defects in dominant oncogenes and tumor suppressor genes, which are involved in various cellular processes such as cell cycle regulation, growth signal transduction, and induction of apoptotic cell death (Minna et al., 1997) . In addition, cytogenetic studies have shown that lung cancer frequently contains chromosomal abnormalities including numerical changes as are also seen in most other cancers (Testa, 1996) .
It is generally accepted that genetic instabilities in human cancers exist at two distinct levels, i.e., nucleotide and chromosome levels . It has been shown in yeast that chromosomal instability can be induced by disruption of the mitotic checkpoint, a highly conserved mechanism that prevents cells with a perturbed spindle assembly from leaving mitosis, thereby improving the ®delity of chromosome segregation (Elledge, 1998; Paulovich et al., 1997; Rudner and Murray, 1996) . Notably, Cahill et al. showed that human colon cancer cell lines with a phenotype of chromosomal instability carried defects in the mitotic checkpoint (Cahill et al., 1998) , while we recently found that the mitotic checkpoint function is also impaired in a signi®cant proportion of human lung cancer cell lines .
Studies on the mitotic checkpoint in yeast and other organisms have resulted in the identi®cation of the MAD and BUB gene families as essential components (Cahill et al., 1998; Li and Benezra et al., 1996; Li and Murray, 1991; Hardwick and Murray, 1995; Hardwick et al., 1996; Hoyt et al., 1991) . To date, however, very little is known about the underlying mechanism of the mitotic checkpoint defects in human cancers. As to genetic alterations of the mitotic checkpoint genes, only a single report has been published on mutations in the BUB1 and BUBR1 genes in a small fraction of colon cancers (Cahill et al., 1998) . In addition, an important insight was recently provided by Jin et al. through a search for molecules associated with the Tax oncoprotein of human T-cell leukemia virus type 1 (Jin et al., 1998) . They established that the Tax-binding protein, originally termed TXBP181, was the human homologue of yeast MAD1 and suggested that it was inactivated by the Tax protein, which would lead to the generation of aneuploidy often seen in virally induced leukemias.
In the present study, we investigated the potential involvement of hMAD1 in the pathogenesis of lung cancers by examining 49 (11 small cell carcinomas, 18 adenocarcinomas, 17 squamous cell carcinomas and three large cell carcinomas) lung cancer specimens taken directly from patients. To this end, we ®rst used Southern and Northern blot analyses to examine 49 lung cancer specimens for the presence of gross alterations in the hMAD1 gene, but could not identify such abnormalities (data not shown). Reverse transcription (RT)-polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) analysis was then performed to search for subtle mutations, yielding three distinct examples with unique electrophoretic mobility shifts (case 37 with the aid of the F3-R3a PCR primer set, case 19 with F4-R4, case 45 with F7-R7) ( Figure 1 and Table 1 ). The distinct mobility shift detected in an adenocarcinoma case (case 19) was found to be present only in the tumor specimen and not in the corresponding normal lung, indicating the somatic nature of the change. Subsequent sequence analysis revealed that this mobility shift was due to a somatic missense mutation (ACG to GCG) at codon 299 (note that the codon coordinate is based on the corrected sequence; see below), which resulted in a non-conservative amino acid substitution of alanine for threonine ( Figure 2 ). The relatively weak intensity of the shifted band seen in RT ± PCR ± SSCP analysis suggested that it could have resulted from either retention of the normal allele and/or inevitable contamination of normal cells, which is often quite signi®cant especially in adenocarcinomas. Accordingly, additional PCR ± SSCP analysis was conducted by using genomic DNAs prepared from microdissected specimens as well as from bulk tumor sample. The results indicated signi®cant contamination of normal cells and retention of the normal hMAD1 allele in tumor cells carrying the somatic mutation, suggesting a dominant negative character of the identi®ed hMAD1 mutation (Figure 3 , data not shown for bulk sample).
The other two distinct amino acid substitutions were detected in a single case each among the 49 cases examined (Figure 1 ) and consisted of amino acid substitutions at codon 160 (case 37, AAC to AGC, asparagine to serine) and codon 556 (case 45, CGC to CAC, arginine to histidine) ( Table 1) . In an additional screening of 156 normal lung RNAs, eight cases exhibited the same mobility shifts as case 37, whereas the distinct band detected in case 45 was found to be unique, suggesting that it may represent a very rare polymorphism or possibly a germline mutation. Unfortunately, detailed past and family histories of case 45 were not available. In the present study, two common polymorphisms at codons 221 and 500 (CAC to CAT, histidine to histidine; and ACG to ATG, threonine to methionine, respectively) as well as two relatively uncommon polymorphisms at codons 511 and 558 (GAG to AAG, glutamic acid to lysine; and CGC to CAC, arginine to histidine, respectively) were also identi®ed (Table 1 and Figure 1 , case 44 carrying both substitutions is shown).
In addition, we noted the presence of a shorter mRNA isoform lacking codons 51 ± 97, the biological Open box, open reading frame; solid box, 5' and 3' untranslated regions. PCR using random primed cDNAs was performed by using oligonucleotide primers in the presence of [ 32 P]dCTP, followed by electrophoretic separation on 6% non-denaturing polyacrylamide gels both in the presence of 5% glycerol at room temperature or its absence at 48C, essentially as described previously (Hibi et al., 1994) . The primer pairs used were: F1 (sense, 5'-CTCTGTAATCGCGAAAGC) with R1 (antisense, 5'-TCTTGTGACTCAGCTCCA), F2 (sense, 5'-AGGTGGAGCGGGAGAAAA) with R2 (antisense, 5'-CCTTCAGTGCGTTGATGG), F3 (sense, 5'-ACAGTCTGGCC-CAGGCTG) with R3 (antisense, 5'-GGAGCCGTACCAGCT-CAG), F4 (sense, 5'-AAGAGCAGGATGCAGCGA) with R4 (antisense, 5'-CTGGAGTCCTGATGCTCA), F5 (sense, 5'-GCTGGGAGAGACTGGACC) with R5 (antisense, 5'-CCAG-GATGGCCCGCATAC), F6 (sense, 5'-TCCTGCTGCTCAC-CAAGG) with R6 (antisense, 5'-CGCCTCCTCCCTGGAGAA), F7 (sense, 5'-CCAGCTCTGCCGAACAGA) with R7 (antisense, 5'-TGCCTCCTCTCT-CCATGG), F8 (sense, 5'-GAGTGCGAG-C-GACTGCGC) with R8 (antisense, 5'-GAGCAGTCGCCT-GGGTGC), and F9 (sense, 5'-GGCTGACCTCGCTGTACG) with R9 (antisense, 5'-GACGTGCACCCAGCCTGT). The PCR ampli®cation was carried out in the presence of either 10% DMSO (F1-R1, F4-R4, F7-R7) or 10% glycerol (F2-R2, F3-R3, F5-R5, F6-R6, F8-R8, F9-R9) for 35 cycles (948C for 45 s, 608C for 45 s, 728C for 45 s) after the initial denaturation step (948C for 5 min). Additional primer pairs were also used to enhance sensitivity due to smaller sizes. These included F3 (sense) with R3a (antisense, 5'-CCTGGAGTTCCTGGATTT) and F3b (sense, 5'-AGGAG-CAGCTGGACCTGC) with R3 (antisense) and the PCR ampli®cation consisted of 35 cycles (948C for 30 s, 608C for 30 s, 728C for 30 s) after the initial denaturation step (948C for 5 min) hMAD1 mutation in lung cancer S Nomoto et al signi®cance of which remains to be determined. We also observed a few consistent disagreements with the published sequence (Jin et al., 1998) . According to our data, it should read GCG CAC CTG instead of GCA CTG between codons 267 and 268, and there is an insertion of C at codon 662 (these codon coordinates are based on a previous report (Jin et al., 1998) ), making the hMAD1 protein more similar in size and alignment to its yeast homologue when compared with the previously reported sequence (Jin et al., 1998) .
Recent molecular biological studies have clearly shown that lung cancer is a disease caused by accumulation of multiple genetic changes in dominant oncogenes and tumor suppressor genes, which play roles as`gatekeepers' in the cell (Minna et al., 1997) . In contrast to colon cancer and a few other tumor types, lung cancer does not exhibit frequent microsatellite instabilities (Gotoh et al., 1999) , and defects in the mismatch repair`caretakers' have never been reported in lung cancer. While numerical changes in chromosomes are common in lung cancer, accumulating evidence points to the possibility that impairment of the mitotic checkpoint may play a role in the generation of aneuploidy Paulovich et al., 1997; Rudner and Murray, 1996) . The present ®ndings clearly indicate that the hMAD1 mitotic checkpoint gene, which is important for maintaining chromosomal stability, is somatically mutated in lung cancer, although with low frequency, and biochemical characterization of the now identi®ed somatic in vivo mutation should shed light on the molecular basis of aneuploidy. Searches for hMAD1 mutations in other types of human solid tumors such as colon cancer may also be rewarding.
To date, only one report has appeared on somatic mutations in the mitotic checkpoint genes in human cancers. By examining 19 colon cancer cell lines preselected for the presence of chromosomal instability phenotype, a hallmark of mitotic checkpoint defects at least in colon cancer, Cahill et al. (1998) found BUB1 and BUBR1 alterations and could con®rm the somatic nature of two BUB1 and one BUBR1 mutations. Considering the occurrence of mitotic checkpoint impairment in about 40% of human lung cancer cell lines , *20 cases of the present cohort could be expected to have had mitotic checkpoint defects. Since PCR ± SSCP analysis usually detects 60 ± 80% of mutations, further studies are warranted to investigate the possibility of hMAD1 dysfunction as the result of other mechanisms such as epigenetic changes and altered protein modi®cations, as well as the potential involvement of other mitotic checkpoint components such as various BUB and MAD genes. In this connection, our previous extensive examination of the same cohort did not yield any evidence of somatic mutations in two additional candidates, hsMAD2 and p55CDC, while our preliminary analysis could not identify any BUB1 alterations in lung cancer cell lines with mitotic checkpoint impairment . Further studies are therefore needed to investigate whether there may be an as yet unidenti®ed major target gene responsible for the mitotic checkpoint defects, or whether there might be a large number of aected genes each playing a role in a small proportion of cases. In addition, from the molecular epidemiological point of view, it would be of interest to investigate the possible relationship of certain amino acid substituting, single nucleotide polymorphism(s) with an increased susceptibility to the occurrence of aneuploidy, since aneuploidy in preneoplastic lesions was found to be present only in individuals whose accompanying lung cancers were aneuploid (Smith et al., 1996) . Figure 2 Sequence analysis of the hMAD1 gene in a lung cancer specimen and the corresponding normal lung sample of case 19. A somatic missense mutation (ACG to GCG) substitutes alanine for threonine at codon 299. Distinctly shifted bands in the RT ± PCR ± SSCP analysis were excised and ampli®ed by using the same sets of primers. PCR ampli®cation products were cloned into the EcoRV site of pBluescript SKII(7) (Stratagene) after polishing, and DNAs prepared from multiple clones of the resulting plasmids were sequenced with the aid of primers used in the PCR ampli®cation essentially as described previously (Nagatake et al., 1996) . RT ± PCR ampli®cation products of the corresponding normal lung RNAs were also subjected to PCR ± SSCP and subsequent sequencing analysis Figure 3 PCR ± SSCP analysis using genomic DNAs prepared from microdissected specimens of case 19. Retention of the normal hMAD1 allele is evident in the lung cancer specimen. M.D., microdissected. PCR ± SSCP analysis using microdissected specimens of formalin ®xed, paran embedded sections was performed for con®rmation at the genomic DNA level, essentially as described previously (Washimi et al., 1995) . The primer pair used was F4a (sense, 5'-TCCAGGAAGAGCTGGAAG) with R4c (antisense, 5'-AGCTCCAAGCCAACCAGC). The PCR ampli®cation consisted of 35 cycles (948C for 30 s, 588C for 30 s, and 728C for 30 s) after the initial denaturation step (948C for 5 min) hMAD1 mutation in lung cancer S Nomoto et al
